+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Influenza Vaccines Market Report 2023-2033

  • PDF Icon

    Report

  • 192 Pages
  • October 2023
  • Region: Global
  • Visiongain
  • ID: 5896235
Description Jump to:
Overall world revenue for Influenza Vaccines Market, 2023 to 2033 in terms of value will surpass US$6,600.0million in 2023. The author predicts strong revenue growth through to 2033. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Influenza Vaccines Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The global prevalence of influenza is on the rise. The most effective method of averting the widespread infection is through vaccination. As the global population ages, individuals become more susceptible to influenza, which increases the demand for influenza vaccines. Increasing awareness of influenza, the improvement of healthcare services, and high birth rates in developed nations will all contribute to increased demand for current and new influenza vaccines during the forecast period. As a result, the influenza vaccine sector exhibits substantial growth prospects and robust revenue generation. Vaccination is a stressful experience, especially for children; therefore, an organisation that provides a non-stressful vaccine stands to gain substantial benefits.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the influenza vaccines market evolving?
  • What is driving and restraining the influenza vaccines market?
  • How will each influenza vaccines submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each influenza vaccines submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading influenza vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the influenza vaccines projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of influenza vaccines projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the influenza vaccines market?
  • Where is the influenza vaccines market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the influenza vaccines market today, and over the next 10 years:

  • Our 192-page report provides 77 tables and 116 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the influenza vaccines market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Vaccine Type

  • Quadrivalent
  • Trivalent

End-users

  • Specialty Clinics
  • Hospitals
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Influenza Vaccines Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • Abbott Laboratories
  • AstraZeneca
  • BIKEN Co., Ltd.
  • CSL
  • Emergent BioSolutions Inc.
  • GSK plc
  • Pfizer Inc.
  • Sanofi
  • SINOVAC
  • Viatris Inc. (Mylan)

How will the Influenza Vaccines Market, 2023 to 2033 report help you?

In summary, the 190+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Influenza Vaccines Market 2023 to 2033, with forecasts for vaccine type and end-users, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Influenza Vaccines Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Influenza Vaccines Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how the work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Influenza Vaccines Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Influenza Vaccines Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Elderly Population Driving Industry Growth
3.2.1.2 Growing Interest in Vaccine Development
3.2.1.3 High Prevalence of Infectious Diseases Anticipated to Spur Industry Growth
3.2.1.4 Increase in Government Focus on Immunization Programs
3.2.1.5 Paediatric Influenza Vaccines Boosting Industry Growth
3.2.2 Market Restraining Factors
3.2.2.1 Inadequate Reimbursement Coverage Likely to Challenge Industry Growth
3.2.2.2 Longer Timelines for Vaccine Development Projected to Hamper Market Growth
3.2.2.3 Supply Chain Constraints
3.2.2.4 Storage and Handling Challenges
3.2.3 Market Opportunities
3.2.3.1 Emerging Economies
3.2.3.2 Personalized Vaccination Strategies
3.2.3.3 Pandemic Preparedness and Stockpiling
3.2.3.4 Education and Public Awareness Campaigns
3.2.3.5 Strong R&D Pipeline
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors
4 Influenza Vaccines Market Analysis by Vaccine Type
4.1 Key Findings
4.2 Vaccine Type Segment: Market Attractiveness Index
4.3 Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
4.4 Quadrivalent
4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Trivalent
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Influenza Vaccines Market Analysis by End-users
5.1 Key Findings
5.2 End-users Segment: Market Attractiveness Index
5.3 Influenza Vaccines Market Size Estimation and Forecast by End-users
5.4 Specialty Clinics
5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Hospitals
5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Others
5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
6 Influenza Vaccines Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Influenza Vaccines Market Analysis
7.1 Key Findings
7.2 North America Influenza Vaccines Market Attractiveness Index
7.3 North America Influenza Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
7.4 North America Influenza Vaccines Market Size Estimation and Forecast by Country
7.5 North America Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
7.6 North America Influenza Vaccines Market Size Estimation and Forecast by End-users
7.7 U.S. Influenza Vaccines Market Analysis
7.8 Canada Influenza Vaccines Market Analysis
8 Europe Influenza Vaccines Market Analysis
8.1 Key Findings
8.2 Europe Influenza Vaccines Market Attractiveness Index
8.3 Europe Influenza Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 Europe Influenza Vaccines Market Size Estimation and Forecast by Country
8.5 Europe Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
8.6 Europe Influenza Vaccines Market Size Estimation and Forecast by End-users
8.7 Germany Influenza Vaccines Market Analysis
8.8 UK Influenza Vaccines Market Analysis
8.9 France Influenza Vaccines Market Analysis
8.10 Italy Influenza Vaccines Market Analysis
8.11 Spain Influenza Vaccines Market Analysis
8.12 Russia Influenza Vaccines Market Analysis
8.13 Rest of Europe Influenza Vaccines Market Analysis
9 Asia Pacific Influenza Vaccines Market Analysis
9.1 Key Findings
9.2 Asia Pacific Influenza Vaccines Market Attractiveness Index
9.3 Asia Pacific Influenza Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Asia Pacific Influenza Vaccines Market Size Estimation and Forecast by Country
9.5 Asia Pacific Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
9.6 Asia Pacific Influenza Vaccines Market Size Estimation and Forecast by End-users
9.7 Japan Influenza Vaccines Market Analysis
9.8 China Influenza Vaccines Market Analysis
9.9 India Influenza Vaccines Market Analysis
9.10 Australia Influenza Vaccines Market Analysis
9.11 South Korea Influenza Vaccines Market Analysis
9.12 South-East Asia Influenza Vaccines Market Analysis
9.13 Rest of Asia Pacific Influenza Vaccines Market Analysis
10 Latin America Influenza Vaccines Market Analysis
10.1 Key Findings
10.2 Latin America Influenza Vaccines Market Attractiveness Index
10.3 Latin America Influenza Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Latin America Influenza Vaccines Market Size Estimation and Forecast by Country
10.5 Latin America Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
10.6 Latin America Influenza Vaccines Market Size Estimation and Forecast by End-users
10.7 Brazil Influenza Vaccines Market Analysis
10.8 Mexico Influenza Vaccines Market Analysis
10.9 Rest of Latin America Influenza Vaccines Market Analysis
11 MEA Influenza Vaccines Market Analysis
11.1 Key Findings
11.2 MEA Influenza Vaccines Market Attractiveness Index
11.3 MEA Influenza Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 MEA Influenza Vaccines Market Size Estimation and Forecast by Country
11.5 MEA Influenza Vaccines Market Size Estimation and Forecast by Vaccine Type
11.6 MEA Influenza Vaccines Market Size Estimation and Forecast by End-users
11.7 GCC Influenza Vaccines Market Analysis
11.8 South Africa Influenza Vaccines Market Analysis
11.9 Rest of MEA Influenza Vaccines Market Analysis
12 Company Profiles
12.1 CSL
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2015-2022
12.1.3.2 R&D, 2015-2022
12.1.3.3 Regional Market Shares, 2022
12.1.4 Product Benchmarking
12.1.5 Strategic Outlook
12.2 Emergent BioSolutions Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2015-2022
12.2.3.2 R&D, 2015-2022
12.2.4 Product Benchmarking
12.3 GSK plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2015-2022
12.3.3.2 R&D, 2015-2022
12.3.3.3 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Pfizer Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2015-2022
12.4.3.2 R&D, 2015-2022
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 Sanofi
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2015-2022
12.5.3.2 R&D, 2015-2022
12.5.3.3 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 AstraZeneca
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2015-2022
12.6.3.2 R&D, 2015-2022
12.6.3.3 Regional Market Shares, 2022
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 SINOVAC
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2015-2022
12.7.3.2 R&D, 2015-2022
12.7.4 Product Benchmarking
12.7.5 Strategic Outlook
12.8 Viatris Inc. (Mylan)
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2015-2022
12.8.3.2 Regional Market Shares, 2022
12.8.3.3 R&D, 2015-2022
12.8.4 Product Benchmarking
12.9 Abbott Laboratories
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2015-2022
12.9.3.2 Regional Market Shares, 2022
12.9.3.3 R&D, 2015-2022
12.9.4 Product Benchmarking
12.10 BIKEN Co., Ltd.
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Product Benchmarking
12.10.4 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks
13.2 Recommendations for Market Players
List of Tables
Table 1 Influenza Vaccines Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Influenza Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Influenza Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Influenza Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Influenza Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Quadrivalent Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Trivalent Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Specialty Clinics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Influenza Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 North America Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 North America Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 North America Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 U.S. Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Canada Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Europe Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Europe Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Germany Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 UK Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 France Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Italy Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Spain Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Russia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Rest of Europe Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Asia Pacific Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Asia Pacific Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 Japan Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 China Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 India Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Australia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 South Korea Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 South-East Asia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Rest of Asia Pacific Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Latin America Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Latin America Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Brazil Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 Mexico Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Rest of Latin America Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 MEA Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 MEA Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 MEA Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 GCC Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 South Africa Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Rest of MEA Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 CSL: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 52 CSL: Product Benchmarking
Table 53 CSL: Strategic Outlook
Table 54 Emergent BioSolutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 55 Emergent BioSolutions Inc.: Product Benchmarking
Table 56 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 57 GSK plc: Product Benchmarking
Table 58 GSK plc: Strategic Outlook
Table 59 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 60 Pfizer Inc.: Product Benchmarking
Table 61 Pfizer Inc.: Strategic Outlook
Table 62 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Sanofi: Product Benchmarking
Table 64 Sanofi: Strategic Outlook
Table 65 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 AstraZeneca: Product Benchmarking
Table 67 AstraZeneca: Strategic Outlook
Table 68 SINOVAC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 SINOVAC: Product Benchmarking
Table 70 SINOVAC: Strategic Outlook
Table 71 Viatris Inc. (Mylan): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Viatris Inc. (Mylan): Product Benchmarking
Table 73 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Abbott Laboratories: Product Benchmarking
Table 75 BIKEN Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 BIKEN Co., Ltd.: Product Benchmarking
Table 77 BIKEN Co., Ltd.: Strategic Outlook
List of Figures
Figure 1 Influenza Vaccines Market Segmentation
Figure 2 Influenza Vaccines Market by Vaccine Type: Market Attractiveness Index
Figure 3 Influenza Vaccines Market by End-users: Market Attractiveness Index
Figure 4 Influenza Vaccines Market Attractiveness Index by Region
Figure 5 Influenza Vaccines Market: Market Dynamics
Figure 6 Influenza Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 7 Influenza Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 8 Influenza Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 9 Influenza Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 10 Influenza Vaccines Market: Porter’s Five Forces Analysis
Figure 11 Influenza Vaccines Market: PEST Analysis
Figure 12 Influenza Vaccines Market Attractiveness Index by Vaccine Type
Figure 13 Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 14 Influenza Vaccines Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
Figure 15 Quadrivalent Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 Quadrivalent Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Trivalent Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Trivalent Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Influenza Vaccines Market Attractiveness Index by Vaccine Type
Figure 20 Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 21 Influenza Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 22 Specialty Clinics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 23 Specialty Clinics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 Hospitals Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Hospitals Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Influenza Vaccines Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 29 Influenza Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 30 Influenza Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %)
Figure 31 North America Influenza Vaccines Market Attractiveness Index
Figure 32 North America Influenza Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 33 North America Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 34 North America Influenza Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 35 North America Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 36 North America Influenza Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 37 North America Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 38 North America Influenza Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 39 U.S. Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 40 Canada Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 41 Europe Influenza Vaccines Market Attractiveness Index
Figure 42 Europe Influenza Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 43 Europe Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 44 Europe Influenza Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 46 Europe Influenza Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 47 Europe Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 48 Europe Influenza Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 49 Germany Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 50 UK Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 51 France Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 Italy Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 53 Spain Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 54 Russia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 Rest of Europe Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 56 Asia Pacific Influenza Vaccines Market Attractiveness Index
Figure 57 Asia Pacific Influenza Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 58 Asia Pacific Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 59 Asia Pacific Influenza Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 60 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 61 Asia Pacific Influenza Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 62 Asia Pacific Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 63 Asia Pacific Influenza Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 64 Japan Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 65 China Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 India Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 67 Australia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 68 South Korea Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 South-East Asia Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 Rest of Asia Pacific Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 Latin America Influenza Vaccines Market Attractiveness Index
Figure 72 Latin America Influenza Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 73 Latin America Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 74 Latin America Influenza Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 75 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 76 Latin America Influenza Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 77 Latin America Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 78 Latin America Influenza Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 79 Brazil Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 80 Mexico Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 Rest of Latin America Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 MEA Influenza Vaccines Market Attractiveness Index
Figure 83 MEA Influenza Vaccines Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 84 MEA Influenza Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 85 MEA Influenza Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 86 MEA Influenza Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 87 MEA Influenza Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 88 MEA Influenza Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 89 MEA Influenza Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 90 GCC Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 91 South Africa Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Rest of MEA Influenza Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 93 CSL: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 94 CSL: R&D, 2015-2022 (US$ Million, AGR %)
Figure 95 CSL: Regional Market Shares, 2022
Figure 96 Emergent BioSolutions Inc.: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 97 Emergent BioSolutions Inc.: R&D, 2015-2022 (US$ Million, AGR %)
Figure 98 GSK plc: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 99 GSK plc: R&D, 2015-2022 (US$ Million, AGR %)
Figure 100 GSK plc: Regional Market Shares, 2022
Figure 101 Pfizer Inc.: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 102 Pfizer Inc.: R&D, 2015-2022 (US$ Million, AGR %)
Figure 103 Sanofi: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 104 Sanofi: R&D, 2015-2022 (US$ Million, AGR %)
Figure 105 Sanofi: Regional Market Shares, 2022
Figure 106 AstraZeneca: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 107 AstraZeneca: R&D, 2015-2022 (US$ Million, AGR %)
Figure 108 AstraZeneca: Regional Market Shares, 2022
Figure 109 SINOVAC: Net Revenue, 2015-2022 (US$ Million, AGR %)
Figure 110 SINOVAC: R&D, 2015-2022 (US$ Million, AGR %)
Figure 111 Viatris Inc. (Mylan): Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 112 Viatris Inc. (Mylan): Regional Market Shares (%), 2022
Figure 113 Viatris Inc. (Mylan): R&D, 2015-2022 (US$ million, AGR%)
Figure 114 Abbott Laboratories: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 115 Abbott Laboratories: Regional Market Shares (%), 2022
Figure 116 Abbott Laboratories: R&D, 2015-2022 (US$ million, AGR%)

Companies Mentioned

  • Abbott Laboratories
  • AstraZeneca
  • BIKEN Co., Ltd.
  • CSL
  • Emergent BioSolutions Inc.
  • GSK plc
  • Pfizer Inc.
  • Sanofi
  • SINOVAC
  • Viatris Inc. (Mylan)
  • Astellas Pharmaceuticals
  • Bharat Immunologicals and Biologicals Corporation Limited
  • Binnopharm
  • Bio Farma
  • BiondVax
  • Bionor
  • Biremx
  • Dynavax
  • Krka Pharmaceuticals
  • MSD Pharmaceuticals
  • Serum Institute of India (SLL)
  • Shionogi Pharmaceuticals
  • Vacsera
  • VaxInnate Corporation
  • Advisory Committee for Immunization Practices
  • Brazilian Ministry of Health
  • Center for Biologics Evaluation and Research
  • Centers for Disease Control and Prevention (CDC)
  • Chinese Food and Drug Administration
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • The Ministry of Health, Labour and Welfare, Japan
  • US Department of Health and Human Services
  • World Health Organization (WHO)

Related Topics

Related Reports

Influenza Vaccines Global Market Report 2024 - Product Image

Influenza Vaccines Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Influenza Vaccines Market and Forecasts 2024-2032 - Product Image

Global Influenza Vaccines Market and Forecasts 2024-2032

  • Report
  • 310 Pages
  • Global
From
Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032 - Product Image

Influenza Vaccine Market Report by Vaccine Type, Technology, Age Group, Route of Administration, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Influenza Vaccine Market by Vaccine Type, Age Group, Administration Route, Distribution Channel - Global Forecast 2025-2030 - Product Image

Influenza Vaccine Market by Vaccine Type, Age Group, Administration Route, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Influenza Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Influenza Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 90 Pages
  • Global
From

About the Flu Vaccine Market

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions. Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques. Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.